Almost 9 months on Fin / Min / Microneedling and Ketoconazole shampoo Finasteride/Dutasteride 8/28/2025
The conversation is about a user's experience with hair loss treatments, specifically using finasteride, minoxidil, microneedling, and ketoconazole shampoo. The user reports improvements after almost nine months, with no side effects, and discusses the shedding process and expectations for results.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity 7 months Fin Treatment Progess
The user has been using finasteride, topical minoxidil, microneedling, red light therapy, ketoconazole shampoo, vitamin supplements, and scalp massages for hair loss since February 2025. They report stronger, thicker hair but are experiencing shedding and are considering increasing finasteride dosage or adding oral minoxidil.
community Minox. 2.5 percent, Finasteride 1.25mg, Microneedling 1.5 mm, Ketoconazole shampoo and Biotin. Got better until it didn’t. Should I start dutasteride and Ru?
User experiencing hair loss tried Minoxidil, Finasteride, Microneedling, Ketoconazole shampoo, and Biotin. Others suggest continuing current treatment for 1-2 years before considering Dutasteride and RU58841.
community 5 months 0.3% finasteride / 7% minoxidil. Trust the process lol
A user shared their positive experience with hair regrowth using a topical treatment containing 0.3% finasteride, 7% minoxidil, ketoconazole, and biotin. They noticed results after about three months, experienced some initial shedding, and had minor headaches as a side effect.
community 4 month Progress picture(finasteride and minoxidil combo)
A user reported significant hair regrowth after 4 months using finasteride and minoxidil, with no major side effects. They are considering oral minoxidil and use microneedling and ketoconazole shampoo.
community 26 months progress – major improvement and stability
A 36-year-old achieved significant hair improvement and stability over 26 months using oral finasteride, minoxidil foam, microneedling, and ketoconazole shampoo, with no side effects. Patience and consistency were crucial for increased hair density and reduced shedding.
Related Research
6 / 6 results
research Androgenetic Alopecia: update on Etiology, Pathophysiology, Diagnosis and Treatment
In this review, the authors explored current and novel treatment options for androgenetic alopecia, noting both FDA-approved pharmacologic treatments like Minoxidil and Finasteride and various non-pharmacologic and surgical methods, including hair transplantation and scalp micro-pigmentation.
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics
This review discusses treatment options for androgenetic alopecia, highlighting the need for personalized, evidence-based approaches but reports no new clinical results.
research Male androgenetic alopecia
This review examines male androgenetic alopecia and reports no new clinical results, offering insights to aid dermatologists in making informed therapeutic decisions.
research Hair Restoration in Androgenetic Alopecia: Looking Beyond Minoxidil, Finasteride and Hair Transplantation
This review discusses the emerging pathophysiological factors and potential new therapies for androgenetic alopecia beyond traditional treatments, but reports no new results.
research Female pattern hair loss: A clinical, pathophysiologic, and therapeutic review
This article discusses treatments for female pattern hair loss, highlighting that oral antiandrogens and topical minoxidil can effectively arrest progression and reverse miniaturization in many patients with mild-to-moderate cases, but it reports no new clinical results.